Cardiovascular diabetology

Genetic links between hormone receptor pathways and healthier aging traits

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated

Abstract

The effects of GLP1R and GIPR/GLP1R agonists on biological aging are currently uncertain.

  • GLP1R agonists are known treatments for diabetes and obesity.
  • GIPR/GLP1R agonists combine effects on both glucose metabolism and appetite regulation.
  • Investigations into their influence on biological aging have not reached clear conclusions.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

Related papers

Sep '25
Genetic evidence that activating GLP1R and GIPR reduces binge drinking and alcohol-related traits across populations
top 2% journal
cited by 13 papers
journal article
Jun '26
How Combined Activation of Two Hormone Receptors May Lower Risk of Eye, Brain, and Heart Disease in Diabetes
top 20% journal
Nov '24
Genetic Support for Targeting GLP-1 and GIP Receptors to Treat and Prevent Fatty Liver Disease
top 5% journal
cited by 7 papers
journal article
Oct '25
Genetic differences in glucose-dependent insulin signals linked to body weight loss and heart disease risk
top 1% journal
cited by 1 paper
journal article
Nov '25
Gene and metabolite networks linked to GLP-1 receptor drugs and related hormone pathways in heart and metabolism health
top 20% journal
cited by 1 paper
journal article

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #54
GLP-1 drugs don't build habits — and that gap is costing patients their results
5 days ago7 studies
issue #53
Semaglutide slowed aging and extended lifespan in older female mice
1 week ago7 studies
issue #52
GLP-1 drugs linked to lower Parkinson's risk in people with type 2 diabetes
2 weeks ago7 studies
issue #51
Semaglutide linked to nearly double the risk of a rare eye condition in people with diabetes
3 weeks ago7 studies
issue #50
A once-daily pill beat placebo on weight loss — and it wasn't semaglutide
4 weeks ago7 studies
issue #49
GLP-1 drugs work even without weight loss — and scientists are finally mapping why
5 weeks ago7 studies
issue #48
Stop the drug, regain the weight: pooled data puts the average rebound at 7%
6 weeks ago7 studies
issue #47
The brain region that explains why blocking and activating the same receptor both cause weight loss
7 weeks ago7 studies
issue #46
GLP-1 drugs linked to lower depression and bipolar disorder risk in large genetic study
8 weeks ago7 studies
issue #45
Stopping GLP-1 drugs linked to higher depression and anxiety risk in type 2 diabetes patients
9 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief